Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer.
Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. — المؤلف: Xiao, Roy — Oncoimmunology
- المؤلف
- Xiao, Roy
- النشر
- Oncoimmunology
- الوصف
- e1471440 p.